SETD2 Regulates Nuclear Division to Achieve Polyploidization in Megakaryocyte

被引：0
|
作者：
Chen, Lei [1 ,2 ]
Liu, Jingkun [1 ,2 ]
Chen, Kunying [1 ,2 ]
Su, Yanxun [1 ,2 ]
Lei, Ying [1 ,2 ]
Si, Jia [1 ,2 ]
Zhang, Jie [1 ,2 ]
Zhang, Zhaojun [3 ]
Zou, Weiguo [4 ,5 ]
Zhang, Xiaohui [6 ]
Rondina, Matthew T. [7 ,8 ]
Wang, Qian-Fei [1 ,2 ]
Wang, Qian-fei [1 ,2 ]
机构：
[1] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing 100101, Peoples R China
[2] China Natl Ctr Bioinformat, Beijing 100101, Peoples R China
[3] Chinese Acad Sci, China Natl Ctr Bioinformat, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China
[4] Shanghai Inst Microsurg Extrem, Shanghai, Peoples R China
[5] Dept Orthoped, Shanghai, Peoples R China
[6] Peking Univ, Natl Clin Res Ctr Hematol Dis, Beijing Key Lab Hematopoiet Stem Cell Transplanta, Inst Hematol,Peoples Hosp,Collaborat Innovat Ctr, Beijing, Peoples R China
[7] George E Wahlen VAMC Geriatr Res & Educ Clin Ctr, Salt Lake City, UT USA
[8] Univ Utah, Sch Med, Dept Med, Div Gen Internal Med, Salt Lake City, UT USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157981
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5730 / 5731
页数：2
相关论文
共 50 条
  • [31] SETD2 — linking stem cell survival and transformation
    Mrinal M. Patnaik
    Omar Abdel-Wahab
    Cell Research, 2018, 28 : 393 - 394
  • [32] SETD2 EXPRESSION AND PROGNOSTIC VALUE IN HEPATOCELLULAR CARCINOMA
    Shi, Hong-Zhou
    Chen, Zi-Yi
    Shi, Xin
    ACTA MEDICA MEDITERRANEA, 2019, 35 (04): : 2039 - 2044
  • [33] Mutations in SETD2 cause a novel overgrowth condition
    Luscan, Armelle
    Laurendeau, Ingrid
    Malan, Valerie
    Francannet, Christine
    Odent, Sylvie
    Giuliano, Fabienne
    Lacombe, Didier
    Touraine, Renaud
    Vidaud, Michel
    Pasmant, Eric
    Cormier-Daire, Valerie
    JOURNAL OF MEDICAL GENETICS, 2014, 51 (08) : 512 - 517
  • [34] Functional Investigation of SETD2 in acute myeloid leukemia
    Ebner, J.
    Skucha, A.
    Grebien, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 79 - 80
  • [35] SETD2: an epigenetic modifier with tumor suppressor functionality
    Li, Jun
    Duns, Gerben
    Westers, Helga
    Sijmons, Rolf
    van den Berg, Anke
    Kok, Klaas
    ONCOTARGET, 2016, 7 (31) : 50719 - 50734
  • [36] Catalytic activity of Setd2 is essential for embryonic development in mice: establishment of a mouse model harboring patient-derived Setd2 mutation
    Chen, Shubei
    Liu, Dianjia
    Chen, Bingyi
    Li, Zijuan
    Chang, Binhe
    Xu, Chunhui
    Li, Ningzhe
    Feng, Changzhou
    Hu, Xibo
    Wang, Weiying
    Zhang, Yuanliang
    Xie, Yinyin
    Huang, Qiuhua
    Wang, Yingcai
    Nimer, Stephen D.
    Chen, Saijuan
    Chen, Zhu
    Wang, Lan
    Sun, Xiaojian
    FRONTIERS OF MEDICINE, 2024, 18 (05) : 831 - 849
  • [37] SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens
    Weng, Yawen
    Xue, Jing
    Niu, Ningning
    CANCER BIOLOGY & MEDICINE, 2024, 21 (09) : 725 - 730
  • [38] An actin-WHAMM interaction linking SETD2 and autophagy
    Seervai, Riyad N. H.
    Grimm, Sandra L.
    Jangid, Rahul K.
    Tripathi, Durga Nand
    Coarfa, Cristian
    Walker, Cheryl Lyn
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 558 : 202 - 208
  • [39] SETD2与肿瘤的研究进展
    杨吉安
    陈谦学
    医学研究杂志, 2017, 46 (09) : 185 - 187+41
  • [40] Roles of SETD2 in LeukemiaTranscription, DNA-Damage, and Beyond
    Skucha, Anna
    Ebner, Jessica
    Grebien, Florian
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (05):
12345